<?xml version="1.0" encoding="UTF-8"?><protocol_summary><protocol><id>16274</id><no>STUDY00009108</no><status>Open</status><title>Multicenter, Randomized, Double Blind, Placebo-Controlled Phase 2a Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Resveratrol (JOTROL) in Parkinson's Disease (RESET)</title><secondary_protocol_no>Admin budget; Pt. care budget</secondary_protocol_no><nct_id>NCT07592767</nct_id><sponsor_type>Industrial</sponsor_type><age_group>Adult</age_group><treatment_type>Treatment</treatment_type><phase>II</phase><scope>Local</scope><disease_site>Other</disease_site><PI>Moussa, Charbel</PI><institution>Georgetown University Medical Center; Lombardi Comprehensive Cancer Center</institution><management_group>GUMC Neurology</management_group></protocol><sipVersion>2026.1.0 Build 16</sipVersion><copyright> &lt;a href="https://advarra.com" target="_blank"&gt;&amp;copy; 2026 Advarra, Inc.&lt;/a&gt; </copyright></protocol_summary>